1. G179(P) What improves diabetes control for young people with high HBA1C in a specialist diabetes centre?. (24th May 2017) Authors: Bailey, J; White, W Journal: Archives of disease in childhood Issue: Volume 102(2017)Supplement 1 Page Start: A72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of timing of randomization after an acute coronary syndrome and subsequent events in patients with type 2 diabetes mellitus: an analysis of the EXAMINE trial. (25th November 2020) Authors: Elharram, M; Sharma, A; White, W; Bakris, G; Rossignol, P; Mehta, C; Ferreira, J; Zannad, F Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pityriasis rosea in sisters. Issue 5860 (28th April 1973) Authors: White, W Journal: BMJ Issue: Volume 2:Issue 5860(1973) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PTU-156 Cost and availability of gluten-free foods in the uk: in store and online. (22nd June 2015) Authors: Burden, M; Mooney, PD; Blanshard, R; White, W; Cambray-Deakin, D; Sanders, DS Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0094 Celecoxib does not increase the risk of cardiac failure, oedema, or hypertension compared to nsaids: results from success 1, a double blind, randomised trial in 13, 274 oa patients. (1st June 2001) Authors: Whelton, A; Singh, G; White, W; Fort, J; Bello, A Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0220 Effects of type I interferon inhibition on blood leukocyte subsets in patients treated in a phase IIB clinical study of anifrolumab in systemic lupus erythematosus (SLE). (15th June 2017) Authors: White, W; Casey, KA; Smith, MA; Wang, L; Sinbaldi, D; Sanjuan, MA; Illei, G Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗